Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03026790 · ClinicalTrials.gov registry record · Phase 2
Veterans' Pain Care Organizational Improvement Comparative Effectiveness Study
A Phase 2 study, sponsored by University of Minnesota.
- Completed
- Registry status
- Phase 2
- Development phase
- 820
- Enrollment target
NCT03026790: Completed Phase 2 study, sponsored by University of Minnesota.
NCT03026790 is a Phase 2 study that has completed, run by University of Minnesota. The registered enrollment target is 820 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (517% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03026790, a Phase 2 study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 820 participants
- Enrollment target
Study Summary
Background and significance: Treatment with opioid pain medications (like hydrocodone and morphine) is common for severe pain, but studies show these medications may not always help and can cause serious problems. High daily doses of opioids can be especially unsafe. To help patients with chronic pain have better quality of life and avoid medication toxicity, health care teams need to manage pain while helping patients reduce opioid medication doses to safer levels.
Primary Outcome
Binary response variable defined by reduction of at least 30% in Brief Pain Inventory (BPI) total score from baseline
Interventions
- DRUG Buprenorphine-Naloxone
- OTHER Medication management
- OTHER Non-pharmacological pain management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 820 participants |
| Start Date | 2017-10-19 |
| Est. Completion | 2022-10-30 |
| Phase | Phase 2 |
What the finished NCT03026790 record still lists
NCT03026790 is an interventional study that assigns participants to a tested intervention. The registered 820 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (517% higher).
The record links to 0 conditions, and to 3 interventions - of which Buprenorphine-Naloxone is the first listed.
NCT03026790 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03026790 about?
NCT03026790 is a clinical study titled "Veterans' Pain Care Organizational Improvement Comparative Effectiveness Study". Background and significance: Treatment with opioid pain medications (like hydrocodone and morphine) is common for severe pain, but studies show these medications may not always help and can cause serious problems. High daily doses of opioids can be especially unsafe. To help patients with chronic pa...
What is the current status of trial NCT03026790?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 820 participants. The study started on 2017-10-19. Estimated completion is 2022-10-30.
What interventions are being tested in trial NCT03026790?
The interventions under investigation include: Buprenorphine-Naloxone (DRUG), Medication management (OTHER), Non-pharmacological pain management (OTHER).
Who is sponsoring clinical trial NCT03026790?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03026790's enrollment target sits among peer trials
820 36th of 2000 higher than 1,965 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04028687 · 820 participants
MDR - PMCF Study for Taperloc Complete Stems
- NCT04613440 · 820 participants · NA
FaCT Trial (Facilitated Cascade Testing Trial)
- NCT04910269 · 820 participants · Phase 3
Outpatient Treatment With Anti-Coronavirus Immunoglobulin
- NCT05679349 · 822 participants · NA
Support and Outreach to Increase Screening for Lung Cancer in Patients With a History of Smoking
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI